MIKROGEN GmbH

Business Strategies: Development and production of test systems, based on recombinant antigens, for serologic diagnosis of viral and bacterial infections. Core Technologies: Genetic engineering of bacterial expression systems for viral and bacterial antigens. Large scale and high efficient production and purification of recombinant and lysate antigens. Development and production of state-of-the-art western blot, enzyme immuno assay (EIA) and rapid assay test systems.

Activity:

Product / Technology type(s) covered:

- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: